A novel use of HIF3A may be as a biomarker for the likelihood of developing obesity or as a biomarker for diagnostic confirmation of obesity-induced sleep apnea. The gene discussed is HIF3A; the disease is obesity due to melanocortin 4 receptor deficiency.